Rabbit Recombinant Monoclonal AP3M1 antibody. Carrier free. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ICC/IF | WB | Flow Cyt (Intra) | |
---|---|---|---|
Human | Tested | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals.
AP-3 complex subunit mu-1, AP-3 adaptor complex mu3A subunit, Adaptor-related protein complex 3 subunit mu-1, Mu-adaptin 3A, Mu3A-adaptin, AP3M1
Rabbit Recombinant Monoclonal AP3M1 antibody. Carrier free. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
The immunogen used for this product(ab251337) shares 78% homologue with AP3M2. (AP-3 complex subunit mu-2). Cross-reactivity with this protein has not been confirmed experimentally.
ab251337 is the carrier-free version of Anti-AP3M1 antibody [EPR16385] ab201227.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
AP3M1 also known as AP-3 complex subunit mu is an important component of the adaptor protein 3 (AP-3) complex. It has a molecular weight of approximately 46 kilodaltons. This protein is expressed in various tissues including neuronal and immune cells indicating its wide-reaching roles in cellular functions. AP3M1 participates actively in cargo recognition and vesicle formation playing a substantial role in the transport and sorting of membrane proteins to specialized compartments within cells.
The AP3M1 protein integrates into the adaptor protein 3 (AP-3) complex which is important for the trafficking of lysosomal membrane proteins. AP3M1 contributes to assembly and stabilization of the AP-3 complex facilitating the recruitment of clathrin and membrane-bound receptors. This indicates the protein's essential role in the maintenance of cellular homeostasis and intracellular protein traffic impacting the delivery of proteins necessary for lysosomal function and integrity.
AP3M1 finds importance in the endosomal-lysosomal pathway and is connected to various cellular processes that manage degradation and recycling of cellular materials. This protein collaborates with other AP-3 complex subunits such as AP3B1 to ensure proper lysosome-related organelles biogenesis. Furthermore AP3M1 intersects with the BLOC-1 (biogenesis of lysosomal organelles complex 1) pathway highlighting its involvement in trafficking and organelle organization specifically in melanosomes and platelet dense granules.
AP3M1 has associations with Hermansky-Pudlak syndrome type 2 and immunodeficiencies. Mutations affecting the AP3M1 function can lead to pigmentary anomalies and immunological defects related to improper lysosomal trafficking. The dysfunction of AP3M1 alongside AP3B1 illustrates its critical role in these diseases as both contribute to the effective formation and function of lysosome-related organelles.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-AP3M1 antibody [EPR16385] ab201227, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-AP3M1 antibody [EPR16385] (Anti-AP3M1 antibody [EPR16385] ab201227) at 1/5000 dilution
Lane 1: HeLa (Human epithelial cells from cervix adenocarcinoma) cell lysate at 20 µg
Lane 2: HEK-293 (Human embryonic kidney) cell lysate at 20 µg
Lane 3: Human fetal brain tissue lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
Exposure time: 10s
This data was developed using Anti-AP3M1 antibody [EPR16385] ab201227, the same antibody clone in a different buffer formulation.Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling AP3M1 with Anti-AP3M1 antibody [EPR16385] ab201227 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) secondary antibody at 1/500 dilution (green). Confocal image showing cytoplasmic staining on HeLa cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).The negative controls are as follows:
-ve control 1: Anti-AP3M1 antibody [EPR16385] ab201227 at 1/250 dilution followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2: Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.
This data was developed using Anti-AP3M1 antibody [EPR16385] ab201227, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed HEK293 (Human embryonic kidney) cells labeling AP3M1 with Anti-AP3M1 antibody [EPR16385] ab201227 at 1/60 dilution (red) compared with a rabbit monoclonal IgG isotype control (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com